Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Investigate the Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone in Patients Receiving Concomitant Chemo-radiotherapy With Weekly Cisplatin for at Least Five Weeks

NCT03668639 is registered in ClinicalTrials.gov with Christina Ruhlmann as lead sponsor.

NCT NCT03668639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03668639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Investigate the Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone in Patients Receiving Concomitant Chemo-radiotherapy With Weekly Cisplatin for at Least Five Weeks
Lead sponsor
Christina Ruhlmann
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 5, 2018
Completion date
April 15, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse event, cervical cancer, chemotherapy-induced nausea and vomiting